1.
Garg A, van der Zee HH, Geng Z, Mulder GD. Impact of Baseline Smoking Status and Body Mass Index in Patients with Hidradenitis Suppurativa Treated with Adalimumab or Placebo in Phase 2 or 3 Studies. J of Skin [Internet]. 2017Oct.27 [cited 2022Aug.8];1(3.1):s130. Available from: https://www.jofskin.org/index.php/skin/article/view/74